Register | Forgot password?
Switch to Arabic
Wednesday, December 2 - 2009
Page navigation Browse related articles

Regional physicians update knowledge of rheumatic diseases

In an effort to support physician education and raise the standards of healthcare provision in the region, Wyeth Pharmaceuticals has sponsored 45 specialists from across the GCC to attend the 8th annual European Union League Against Rheumatism (EULAR 2007) which recently concluded in Barcelona.

Article continues below
 
The conference endeavors to communicate new knowledge about improved prevention of rheumatic diseases and better treatment and rehabilitation of patients with these disorders. It also acts as a meeting point for rheumatologists, health care professionals and patients where they can exchange ideas and develop plans for future research and education.

One of the major topics discussed at the conference was the importance of early diagnosis in the treatment of Rheumatoid Arthritis (RA). RA is characterized by the presence of joint swelling associated with pain and stiffness and it affects one person in every hundred in the Middle East. The conference reported that patients presenting with arthritis should be referred to and seen by a rheumatologist within six weeks after the onset of symptoms and that the main goal of RA treatment is to achieve remission. It also emphasized the importance of patient education on the treatment and outcome of the disease.

"The management of different Rheumatic Diseases varies widely among countries, doctors and settings so international events such as the EULAR conferences are crucial in obtaining a set of recommendations and standardized operating procedures. Getting the opportunity to meet with international experts in the field allows for increased knowledge and access to the latest up dates in the treatment and management of rheumatic diseases," says Dr Hussein Al Halabi, Consultant Rheumatologist, King Faisal Hospital, Jeddah, KSA.

The 4 day event included conferences with Continuing Medical Education (CME) accreditations which focused on the substantial burden of rheumatic diseases and the impact on the quality of life of sufferers. The seminars included science and clinical symposia, abstract sessions, presentation and discussion of difficult cases, workshops and special interest group sessions.

"Rheumatic Diseases are crippling our society and continue to have a serious impact on the quality of life of sufferers across the Middle East. We need to improve awareness and further re-enforce the idea that living successfully with these disorders begins with education," comments Dr Hussein Al Halabi.

The management of rheumatic conditions in the Middle East continues to be challenging and we welcome all initiatives to promote the spread of knowledge in the region,"


he continued.
Also consider reading:
Log in to request more information from Wyeth

Notes and media contacts

About Wyeth

Wyeth Pharmaceuticals, a division of Wyeth, has leading products in the areas of women's health care, cardiovascular disease, central nervous system, inflammation, transplantation, hemophilia, oncology, vaccines and nutritional products. Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing, and marketing of pharmaceuticals, vaccines, biotechnology products and nonprescription medicines that improve the quality of life for people worldwide. The Company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.

For more information please contact:

Bashar Kharbat
Asda'a Public Relations
T: 966 2 6575195
F: 966 2 6575277

Disclaimer:

Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com

Any opinions, advice, statements, offers or other information expressed in this section of the AMEinfo.com Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / Emap Limited. AME Info FZ LLC / Emap Limited is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AMEinfo.com Web site.

For details about submitting your stories, please read the guide - all content published is subject to our terms and conditions